In this episode of The Truth, Lies & Alzheimer’s Podcast, Lisa Skinner explores the growing conversation around the p-tau217 blood biomarker test and its potential role in identifying Alzheimer’s-related biological changes.

P-tau217 can provide valuable information about the likelihood of Alzheimer’s-related amyloid and tau pathology, but a result is not the same as a dementia diagnosis and cannot predict exactly if or when symptoms will develop.

Lisa discusses:

• What the p-tau217 biomarker test measures
• What a positive or negative result may mean
• Why results should not be viewed as a guarantee or prediction of the future
• The importance of symptoms, medical history, other testing, and clinical evaluation
• Questions to consider before deciding to be tested
• How testing may help provide direction for next steps rather than simply another number

The key question may not be just, “Should I get tested?” but rather, “What am I hoping to learn, and what will I do with the information?”

Hashtags

#Alzheimers #Dementia #DementiaCare #PTau217 #AlzheimersResearch #Biomarkers #MemoryLoss #BrainHealth #CognitiveHealth #DementiaAwareness #CaregiverSupport #TheTruthLiesAndAlzheimers